Pluristem Therapeutics Inc (PSTI)

[Scott999]

Yes we are 5 weeks in to the second half. So according to their January presentation, they have accomplished one out of six so far.

Data readout ARS 1H - YES
Preclinical Data Fukushima 1H - NOPE
Preclinical Data NYBC 1H - NOPE
ARS contract H2 - TBD
Initiation pivotal trial H2 - TBD
Data readout HCT H2 - TBD

And if you throw in the forever "coming months" with Sosei deal, that would be a failure as well.

I don't see what is wrong with pointing out the constant misses this company seems best at. You don't think our share price is because of that? Maybe if they had a couple of steel ones in their pocket, they could do conference calls where the could communicate with shareholders more effectively, and answer some tough questions I'm sure many would want to ask.

But everyone should just keep taking their word on things. Two out of three missed so far this year. Who cares. Three more to see if they will miss. How is HCT trial progressing. Who cares. Must not be going as planned or we would have had that data. But again who cares.

Management must be held accountable for their words. Their misses have been going on for those 8 years, and don't see anything wrong with complaining about it. Criticism is well justified and deserved.